How SARS-CoV-2 impacts astrocyte function in neurocovid-19 and what this means for brain health, neurological symptoms, and ...

Researchers from University of Tsukuba and Institute of Science Tokyo have identified nonrandom patterns in the emergence of ...

Long COVID symptoms persist in over half of HCWs nearly 4 years after ancestral SARS-CoV-2 infection, despite a reduced overall burden.

Researchers analyzing 761 first-trimester pregnancies found that SARS-CoV-2 was rarely detected in placental tissues, ...

A new study suggests that COVID-19 may slightly increase the risk of lung cancer by triggering a biological chain reaction in ...

The GVN is monitoring the SARS-CoV-2 variant BA.3.2, sometimes informally referred to in media reports as the “cicada” variant, and emphasizes that current evidence does not indicate cause for alarm o ...

Researchers have discovered that SARS-CoV-2, the virus that causes COVID-19, may be changing crucial white blood cells called neutrophils so that instead of working to destroy pathogens, they instead ...

UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...

Even if a virus escapes our antibodies and causes infection, our immunity wall protects us from severe disease.” ...

Researchers have discovered that SARS-CoV-2 hijacks three important host proteins that dampen the activity of the complement system, a key component of early antiviral immunity. This significantly ...